News

Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...
The 71-year-old believed the bleeding was a side effect of the antiplatelet drugs he had been taking. Read more at ...
Patients who received a single antiplatelet drug therapy— usually aspirin — after transcatheter aortic valve replacement (TAVR) had about half the risk of dying in the subsequent 6 months ...
WebMD examines antiplatelet drugs, a group of powerful medications that prevent the formation of blood clots. Learn more about antiplatelet drugs and heart disease.
CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions ...
Aloe vera has a reputation for healing in the holistic health community, but what's real and what's still being discovered? A ...
By Drug Class: The adenosine diphosphate (ADP) receptor inhibitors segment dominated the antiplatelet market in 2023, owing to well-established efficacy and safety profiles of ADP receptor inhibitors.
Both are essential in treating conditions caused by blood clots such as heart attack and stroke, but they work in different ...
Anticoagulant or antiplatelet drugs, sometimes called blood thinners, help prevent blood clots. There are many options, including heparin and warfarin. Preventing clots reduces the risk of stroke ...
Dual antiplatelet therapy (DAPT) is used to help prevent blood clots following a stroke or heart attack and for other conditions that may cause blood clots.
Low-dose aspirin as an antiplatelet therapy is the drug of choice for preventing cardiovascular events, but the potential risk of bleeding has limited its use in myeloproliferative neoplasms in the ...
PhaseBio Pharmaceuticals, Inc. PHAS reported interim data from the ongoing phase III REVERSE-IT study evaluating its lead product candidate bentracimab to reverse the antiplatelet effects of blood ...